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This review article presents the most appropriate strategies for examining the 
phenotype for personality disorders. At present there are many neurobiological and 
molecular studies that suggest a genetic predisposition to different traits representative of 
expressed personality disorders. Nonetheless, it has not been possible to accurately and 
successfully replicate such results due to some difficulties regarding the sensitivity, 
specificity and validity of the clinical evaluation methods, and the size and type of the chosen 
population and experimental designs used for research. Unfortunately, diagnoses done in 
psychiatry and psychology have a classification system based on the prevalence and 
intensity of symptoms and do not take into account the etiology, neurobiology, epidemiology, 
genetics, and drug responses.  On the other hand, explaining the phenomenology of 
personality disorderes and how genes work together to express this phenotype implies a 
revision of the chaos theory, addressing the connection between neurodevelopment, 
significantly stressful events during early childhood and epigenetic modifications in DNA 
related to stochastic events which may contribute to the development of normal or abnormal 
behavior 
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Este artículo de revisión presenta las estrategias más apropiadas para el estudio 
de endofenotipos en los trastornos de personalidad. Actualmente existen muchos estudios 
neurobiológicos y moleculares que sugieren una predisposición genética a diferentes 
rasgos representativos expresados en dichos trastornos. No obstante, la replicación exitosa 
de tales resultados no ha sido posible, debido a dificultades relacionadas a la sensibilidad, 
especificidad y validación de los métodos implementados en las evaluaciones clínicas; el 
tamaño y tipo de poblaciones elegidas, y los diseños experimentales implementados. 
Desafortunadamente, los diagnósticos hechos en psiquiatría y psicología cuentan con un 
sistema de clasificación basado en la prevalencia y la intensidad de los síntomas, sin tener 
en cuenta la etiología, neurobiología, epidemiología, genética y la respuesta a los 
medicamentos. Por otra parte, explicar la fenomenología de los trastornos de personalidad 
y como los genes expresan el fenotipo, implica una revisión de la teoría del caos, 
direccionándola a la conexión entre en neurodesarrollo, eventos estresantes significativos 
durante la infancia temprana y modificaciones en el ADN asociados a eventos estocásticos 
que contribuyen al desarrollo de conductas normales y anormales.  
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1. INTRODUCTION 
 
The costs in terms of public health for personality 
disorders in developing countries have not been 
established yet. However, we do know that conducts 
caused by these disorders decreases the quality of life 
and a significant loss in human capital.  Personality 
disorders are a serious mental health condition 
responsible for individual history for criminal arrest, 
interpersonal violence and suicidal behaviors. 
Additionally, personality disorders are associated with 
medical morbidity and mortality (Samuels, 2011). 
 
2. PREVALENCE OF PERSONALITY DISORDERS 
 
Personality disorders (PD) are described by the the 
American Psychiatric Association and Statistical 
Manual of Mental Disorders, Fifth Edition (DSM-5) as 
“an enduring pattern of inner experience and behavior 
that deviates markedly from the expectations of the 
individual's culture, is pervasive and inflexible, has an 
onset in adolescence or early adulthood, is stable over 
time, and leads to distress or impairment.”  
The DSM-5 identifies ten PD grouped into three 
clusters based on descriptive similarities. See table 1. 
Data submitted by The National Epidemiologic Survey 
on Alcohol and Related Conditions (NESARC), 
estimated that 15% of adult North Americans fulfill the 
criteria for a personality disorder. Conforming to the 
DSM-5 the prevalence for disorders in cluster A is 5.7%, 
cluster B, 1.5% for cluster C, 6.0% and 9.1% for any 
personality disorder. (DSM-5, 2013). See table 1. 
 
The occurrence of antisocial personality disorder 
(ASPD) worldwide fluctuates between 1 and 3% 
(Blanco et al., 2010; Goldstein & Grant, 2009) a number 
similar to the schizophrenia or bipolar affective disorder 
type. However, the biomedical studies are enormous 
(Cuartas Arias et al., 2011) for last ones in comparison 
with ASPD; this means that the negative impact that 
entails ASPD for individuals and societies has not yet 
been evaluated enough and this constitutes a harmful 
phenomenon in the development and collective mental 
health, as well as its high cultural and social cost.  
The rates of occurrence vary according to the culture 
and context in which the patterns of behavior 
characteristic for PD are established. Therefore, there 
is no general consensus worldwide. 
Generally PD has a chronic course, although there is 
evidence of a decrease in bizarre behaviors after the 
age of 40, which allows for an important variation in the 
decrease and severity of the symptoms along with the 
increase of the age (Boutwell & Beaver, 2008; 
Huchzermeier et al., 2008). 
 
 
Table 1. Classification of Personality Disorders DSM V 
 
Clusters  Characteristics  Personalityn Disorders 
Cluster A Odd or eccentric 
Paranoid 
Schizoid 
Schizotypal 
Cluster B Dramatic, emotional or erratic 
Antisocial 
Borderline 
Histrionic 
Narcissistic 
Cluster C Anxious or fearful 
Avoidant 
Dependent 
Obsessive- compulsive 
 
 
 
3. THE CONCEPT OF BIOMARKER 
 
It is important to take into account that a biomarker is 
just an indicator of biological processes since it does 
not play a causal role within the course of a disease 
and, thus, it may be akin to a biological signal which 
points towards the presence of a specific pathology – 
for example, melatonin levels as a biomarker for 
schizophrenia (Carmeli, Knyazeva, Cuenod, & Do, 
2012; Morera, Abreu-Gonzalez, Henry, & Garcia-
Hernandez, 2009). According to this, it is usual that 
biomarkers be measurable substances – for instance, 
macromolecules like proteins – which are used to 
assess the presence and risk of a particular organic 
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disorder. Hence, a general notion about what 
constitutes a biomarker is to regard it as an objectively 
measurable feature which can assess normal and 
pathological conditions so that it is used as an indicator 
of the presence of and degree at which a biological 
process is directly linked to clinical products and 
symptoms of a particular disease (Courtet, Gottesman, 
Jollant, & Gould, 2011; DiLalla & Gottesman, 1991). 
It is remarkable to highlight three points that Ritsner and 
Gottesman (2009) expose in order to determine a 
biomarker’s efficacy, namely, 1) a biomarker must 
depict a basic physiopathological process and detec a 
fundamental characteristic of the disorder; 2) a 
biomarker must be specific for a pathology in contrast 
with others; and 3) a biomarker must not consist in clinic 
symptomatology (Bertelsen, 2011). 
In addition to the general definition that has been given 
of a biomarker, it should be noted that depending on the 
field of application there may be several sorts of 
biomarkers (Ritsner & Gottesman, 2009, pág. 6). 
Thereby, in accordance with the purpose of this article 
we classify biomarkers as depicted in table 2. 
 
 
Table 2. Biomarkers Clasifiaction  
 
Categories Biomarkers Authors 
rmonal biomarkers 
endocrinological markers for assessing the vulnerability to a 
specific disorder. For example: adrenocorticotropin hormone 
(ACTH), testosterone-cortisol ratio, and hypothalamic-pituitary-
adrenal (LHPA) axis 
(Anthenelli, Maxwell, Geracioti, & 
Hauger, 2001; Terburg, Morgan, & 
van Honk, 2009). 
Neurophysiological 
biomarkers 
It concerns brain potentials, and changes in sensorial and 
galvanic responses. For example, event-related potentials, 
electroencephalography, autonomic stress reactivity (startle 
reflex modulation, Skin conductance reactivity, 
electromyography, heart rate, and pupillary reflex 
(Lobbestael, Arntz, Cima, & 
Chakhssi, 2009; Meijer, Smulders, 
Johnston, & Merckelbach, 2007), 
response, brain abnormalities 
(Magnetic Resonance Imaging), 
(Boccardi et al., 2011; Hecht, 2010; 
Huebner et al., 2008) 
Neuropsychological 
biomarkers: 
It concerns changes in higher psychological functions involved in 
the efficient processing of information. For example, executive 
function, attention network, psychomotor performance, decision 
making 
(Carlson & Thai, 2010; Fairchild et 
al., 2009; Racer et al., 2011), 
reaction Time (Blair et al., 2006), 
deficits in facial affect recognition, 
emotional processing, working 
memory processes (Boccardi, et al., 
2011; Marsh & Blair, 2008; Prehn et 
al., 2012). 
 
 
 
 
3.1 Biomarkers and Endophenotypes  
It should be remarked the difference which exist 
between biomarkers, and another concept whose 
function is also, partly, to give an account of biological 
processes: the endophenotype. This term, also known 
as an intermediate phenotype, was originally treated as 
an internal phenotype that could be used as a clinic 
variable far more rigorous in the studied phenotype, 
thus, being more reliable to genetic searches. Some of 
the most outstanding characteristics belonging to 
endophenotypes are depicted in table 3. However, the 
most important component of an endophenotype which 
distinguishes it from a biomarker is that it is intended to 
be an intermediary variable in the causal course of 
pathologies (Benjamin, Ebstein, & Belmaker, 2001, 
pág. 54) through the identification of genetic 
polymorphisms which are associated with particular 
effects in neuronal function, physiology and 
neurocognition (Glenn, 2010). Hence, it is this causal 
role which differentiates endopehnotypes from 
biomarkers – the latter being only risk indicators of 
biological processes, but not playing any causal role 
(Ritsner & Gottesman, 2009, pág. 7)Having carried out 
this distinction between endophenotypes and 
biomarkers it is possible to conclude that a biomarker 
merely points to the physiological expression of 
particular morphological, biochemical or molecular 
conditions which are closely related with the state of a 
disease or syndrome. Therefore, a candidate biomarker 
must be sensible, specific, reversible, and replicable in 
pharmacodynamics. Nevertheless, although a 
biomarker’s expression may vary in short time intervals 
(from hours to days), it is plain over time. 
 
         Valencia and Cuartas (2016) int.j.psychol.res. 9 (1) PP. 98 - 112 
 
100 
  R E V I E W 
  INTERNATIONAL JOURNAL OF PSYCHOLOGICAL  RESEARCH Biomarkers in Personality Disorders 
 
 
3.1.1 Endophenotypes in PD 
The study of endophenotypes provides evidence to 
identify the basis genotypes, which are strongly 
correlated with the traits of the PD. Moreover, these 
basis can provide information about the susceptibility to 
those disorders.  As previously mentioned, studies 
designed with twins, families and adoptive families as 
well, suggests that a genetic component is involved not 
only for personality but also for PD (Siever, 2005). Due 
to the stability of the traits in PD, the studies based on 
endophenotypes are facilitated. These traits and 
interactive dimensions can be formulated into the 
laboratory for behavioural and neurobiological 
endophenotypes, which provide close understanding of 
underlying genotypes (Siever, 2005). Some of the 
clinical dimensions studied under the paradigm of 
endophenotypes are impulsivity, aggression, emotional 
information processing, attention, working memory, 
among others. Adittionally, the electrophysiological 
measures can be applied to diagnosis, prevention and 
treatment of the PD or various clinical conditions 
(Kamarajan & Porjesz, 2015).  
 
3.2 Biomarkers and Development in PD 
Obstetric complications can become markers of 
vulnerability in the expression of psychopathic features; 
this condition could originate neurological damages and 
susceptibility to the development of PD. On the subject, 
Allen and colleagues evaluated in 1998 some such 
factors associated with pregnancy and birth labor as 
family relations, prematurity and the consumption of 
tobacco and observed that obstetric complications were 
associated with the occurrence of an agitated behavior, 
impulsivity and antisocial acts. Some obstetric 
complications were related to the mother’s emotional 
disorders during pregnancy; additionally, neonatal 
anoxia is a significant factor of risk of ASPD disorder 
(Allen, Lewinsohn, & Seeley, 1998; Wermter et al., 
2010). Raine and his group carried out a longitudinal 
research evaluating the relations between obstetric 
complications and the subsequent occurrence of 
psychopathology in a sample of 4269 newly born 
individuals.  
Some of the variables such as socioeconomic situation, 
mental characteristics of the mother, as well as 
rejection from the mother (attempt to abort, the 
abandonment of the child) were also analyzed, showing 
that the rejection from the mother, summed up to some 
obstetric complications were associated significantly to 
violent acts in the future (Raine, Brennan, & Mednick, 
1997). In other studies prenatal problems such as 
preeclampsia, umbilical cord prolapse and prolonged or 
induced birth labor, have been associated with the 
occurrence of violent behavior between the age of 6 
and 17 years (Allen, et al., 1998; Bahmanyar, 
Montgomery, Weiss, & Ekbom, 2008). 
On the other hand, consumption and exposure to toxic 
substances could be considered as a potential 
endophenotype for the development of aggressive and 
impulsive forms of behavior, due to the fact that the 
fetus is affected in its normal development if 
psychoactive substances are consumed during 
pregnancy. The implications of tobacco consumption 
during pregnancy were analyzed by Fergunsson and 
collaborators in their prospective research during 18 
years with 1265 children, in which they found that the 
excessive consumption of tobacco is associated with 
the occurrence of a higher number of paidopsychiatric 
disorders, such as dissocial disorder and alcohol 
consumption (Fergusson, Woodward, & Horwood, 
1998). 
These findings were supported by those of Brennan 
who found in a retrospective study of a historical cohort 
of 4169 individuals which ones had committed 
antisocial acts, a positive relation between the quantity 
of consumed tobacco and violent acts during 
adolescence and adult age (Brennan PA, 1999). The 
consumption of tobacco and maternal use of alcohol 
during pregnancy could have implications on the 
noradrenergic, serotonergic and dopaminergic circuits, 
which have a negative influence on brain and 
development (Brookes et al., 2006; Wermter, et al., 
2010).  
 
3.3 Biomarkers in receptors and neurotransmitters 
for PD 
The Biogenetic Amines have been a research focus in 
view of their involvement in the presence of violent 
behavior. In general terms, serotonin (5-HT) has an 
inhibitive action in the brain (Daw, Kakade, & Dayan, 
2002); the serotonergic dysfunction has been 
frequently associated with aggressive behavior in 
animals and human beings.  
In primates, low concentrations of 5-HIAA have been 
related to recidivist behavior of aggression and 
impulsivity (Dongju Seo, 2008; Fairbanks, Melega, 
Jorgensen, Kaplan, & McGuire, 2001; Mehlman et al., 
1994), and to poor impulse control (Mehlman, et al., 
1994). In contrast, the low concentrations of 5-HIAA 
have repeatedly been associated with aggression 
through lifetime in individuals with some kind of mental 
disorder, either violent suicide, impulsivity or recidivist 
homicidal acts (Dongju Seo, 2008; Moore, 2002). In 
accordance with these findings, Moore and 
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collaborators carried out a meta-analysis including 20 
different studies in which it is evident that low levels of 
serotonin contributed to impulsive behavior, which was 
even correlated to some kind of crime. Different studies 
have demonstrated the association of PD with a 
decrease of the function of the serotonergic system. 5-
HT is perhaps one of the neurotransmitters that has 
been most studied since it modulates a series of 
biological and psychological functions such as the 
endocrine regulation, the state of mind, the libido, the 
regulation of aggression, and so on. Moreover, the 5-
HT receptors have repeatedly been associated with 
impulsivity and aggressive behavior in different types of 
animal models, in which researchers have tried to 
recognize the type of aggression it expresses 
Although the relations between the hypofunction of 
serotonin and the impulsive behavior have been 
consistent with the contributions of clinical 
neurosciences, there are still few studies that detail this 
relation.  It has been suggested that the serotonergic 
hypofunction and its strong association with impulsive 
behavior could have a genetic base such that the 
deficiency in the serotonin function could constitute a 
neurochemical biomarker of impulsive behavior 
(Dongju Seo, 2008). Another molecule that has been 
interesting and that could end up as a biomarker in PD 
refers to free l-tryptophan plasmatic levels  of 
tryptophan, amino acid, precursor of 5-HT, which is co-
related with high rates on the scales of aggression 
(Moller et al., 1996). So far, free l-tryptophan and 
competing amino acids have could be useful in early 
indicators for the development of impulsive behavior 
(Virkkunen et al., 2003).  
Likewise, the variation in MAO-A (monoamine oxidase 
A), has been co-related with the reduction of 
aggression in mice, probably as a result of the increase 
in the levels of 5-HT (Nelson & Chiavegatto, 2001). It is 
known that a reduction of the activity of the platelet 
MAO-A is related with impulsivity and PD and that it is 
also associated with 5-HAA in LCR, thus presenting an 
inverse correlation with rates at scales that search for 
sensations and impulsivity (Schalling, Asberg, Edman, 
& Oreland, 1987).  In addition, recent studies have 
replicated of gene x environment (G x E) interactions 
involving the MAO-A, indicating that activity MAO-A 
genetic variant who were more associated to PD traits 
like as hostility and impulsivity (Fergusson, Boden, 
Horwood, Miller, & Kennedy, 2011; Philibert et al., 
2011; Reti et al., 2011) 
 
3.4 Biomarkers of Emotional Expression 
The implications of facial expression were initially 
formulated by Charles Darwin in 1872; later, a lot of 
researches have suggested that the basic emotions in 
human beings can be identified through facial 
expressions and brain activation (Panksepp, 1992; 
Ortony Turner &, 1990). Regarding individuals with PD, 
studies with PET have shown that a low level of 
activation in the ventromedial prefrontal area could 
influence a brain circuit which depicts a biomarker in 
which there are impairments in the monitoring of 
feelings and emotions of oneself and others. 
Supporting this, it is suggested that in these individuals 
the contra-lateral region of the right hemisphere is 
related to their failure to process emotional expressivity 
which explains why their faces seem not to be altered 
when emotional asymmetric differences occur.  
Facial asymmetries are produced by several 
anatomical, physiological, neurological, psychological, 
pathological and socio-cultural factors. From 
neuropsychology it has been pointed that facial 
expressions correspond to asymmetries in brain 
functions (Borod, Haywood, & Koff, 1997). Thereby, the 
fact that from psychosocial vulnerability factors several 
biomarkers related to neuronal circuits (involved in 
facial asymmetries) may be derived is remarkable 
(Borod, et al., 1997).  Particularly, the emotional 
deprivation that implicates a limit to the possibilities of 
establishing relations between affection and empathy – 
a condition that is co-related with the presence of 
psychopathic features – could lead to an emotional 
malfunction that is expressed by facial configurations 
that are controlled by both brain hemispheres 
(Birbaumer et al., 2005; Caspi et al., 2002; Dolan & 
Fullam, 2006; Kosson, Kosson, Lorenz, & Newman, 
2006; Marsh & Blair, 2008). Corroborating this, Facial 
analyses show a reduction in the activation of the right 
brain hemisphere and the prefrontal ventromedial 
cortex, and a deficit in the function of the amygdala 
(which is associated with recognition and perception of 
expression of fear and sadness). 
 
4. NEUROPHYSIOLOGICAL BIOMARKERS FOR 
PD 
 
Psychophysiology (electroencephalogram and event-
related potentials), positron emission tomography 
(PET), single photon emission computed tomography 
(SPECT) and magnetic resonance imaging (MRI), all of 
them have allowed to decipher the brain areas 
implicated in PD. These methods help detect the 
activation of structures, in response to physiological or 
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cognitive tasks and a deficit in the emotional reactivity 
has been reported. Several studies have reported 
reduced P3 amplitude in bipolar disorder and ASPD, 
also, this is a multi-determined component indexing 
attention and working memory processes related to 
executive function. These data support the deficient 
startle potentiation and suggesting that ASPD traits are 
associated with distinctive information-processing 
characteristics as indexed by P3 amplitude. (Anderson, 
Stanford, Wan, & Young, 2011; Carlson & Thai, 2010). 
In a recent study Hall, M. et al. (2015), conducted a 
genomewide association analysis of 
electrophysiological endophenotypes study for some 
PD, schizophrenia and psychotic bipolar disorder. They 
identified a region on chromosome 14 that was 
significantly associated with sensory gating. Peak of the 
Single nucleotide polymorphism (SNP) (rs10132223, P 
= 1.27×〖10〗^ (-9)). In the polygenic risk scores 
between genetic components of event – related 
potentials (ERP) and mood and psychotic disorders, 
they found that patients with higher load of 
esquizofrenia risk alleles had reduced gamma 
responses while patients with higher load of bipolar 
disorder risk alleles had smaller P3 amplitude.  
To research efficiently into a biomarker (related with the 
emotional imbalance in personality disorder) which 
indicates the presence of emotional stable or instable 
devices to face situational stress, some other 
physiological measurement must be used, namely, 
such an interesting variable as the electromyography 
evaluation (Herpertz et al., 2001; Lang, Greenwald, 
Bradley, & Hamm, 1993). The electrodermal response 
is an indicator of emotional arousal and of the 
spontaneous responses of alert present in the 
processing of emotional stimuli. The evaluation of this 
endophenotype has evidenced that it is difficult to 
respond adequately to aversive stimuli and balance 
between a stimulus’ positive and negative features in 
PD.  
Undoubtedly, one of the areas of the brain cortex most 
implicated in the irregular expression of PD is the 
orbitofrontal cortex; damages in this area implicate 
behavior changes and neurocognitive malfunction 
(Stevens, Kaplan, & Hesselbrock, 2003). With the use 
of evoked potentials, a decrease of the amplitude of the 
P300 wave has been observed in the frontal electrodes 
of individuals with high rates of aggressiveness (Bauer 
& Hesselbrock, 2001; Benning, Patrick, & Iacono, 2005; 
Kostandov, Tal'tse, Zakharova, & Vazhnova, 1994; 
Patrick et al., 2006). One of the most consistent 
approximations for the studies of endophenotypes 
related with PD has been the use of neuroimage tools, 
which have associated impulsivity with a reduction of 
the volume of the prefrontal grey substance and with a 
decrease in the perfusion of the temporal cortex and in 
the ventrolateral area at the right of the prefrontal 
cortex.   
A neural dysfunction and white matter microstructural 
abnormality in the inferior frontal regions has been 
associated with PD (Hoptman, 2003; Narayan et al., 
2007; Sundram et al., 2012). Through the use of the 
PET it has been possible to associate a decrease in 
brain fluid on the left side of the orbitofrontal cortex, the 
right side of the ventral cingulated area and the bilateral 
temporal poles, with violent behavior (Dougherty et al., 
1999; Hoptman, 2003).  With the use of the SPECT, 
patterns of behavior have been found characteristic of 
some PD, e.g; ASPD which is associated with a 
prefrontal hypoperfusion and an increase in blood fluid 
in the anteromedial frontal region and the left zone of 
the basal gland in the lymphatic system (Amen, 
Stubblefield, Carmicheal, & Thisted, 1996). 
Likewise, some studies reported a significant 
association with a decrease in gray matter temporal 
brain regions, in particular in the right superior temporal 
gyrus, this findings supporting the hypothesis that a 
disturbed frontotemporal network is critically involved in 
the pathogenesis of general PD (Muller et al., 2008; 
Soderstrom et al., 2002). As a result of these multiple 
findings a hypothesis has been suggested to explain 
the low functioning of some brain systems in 
psychopathology: it seems that these individuals, in 
order to compensate for deficits in the prefrontal 
lymphatic circuit, use the dorsolateral prefrontal cortex, 
which explains the deficits in the emotional processing 
and the execution of basic cognitive tasks. Up to now, 
one of the central problems of neuroimaging studies is 
co-morbidity and therefore the differential identification 
of affected brain regions. Specifically for PD, 
associated with alcoholism, drug addiction, PD in 
general could show significant correlations in the same 
regions of interest. At present, neuroimaging studies for 
quantitative features that include clinical dimensions 
and diagnostic evolution have not had conclusive 
results for the etiopathology of these disorders. 
Nevertheless, the use of neuroimage and 
psychophysiological tools help configurate diagnostic 
subtypes that best decipher the etiology of the 
syndrome.  
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5. BEHAVIORAL BIOMARKERS RELATED TO 
NEUROCHEMICAL AND HORMONAL 
VARIABLES IN PD 
 
Initially, impulsive behavior has been associated with 
endocrine pathologies such as Cushing’s syndrome, 
hyperandrogenism, hyperthyroidism, hypoglycemia, 
and premenstrual syndrome, but these findings are still 
controversial. In this regard, it has been suggested that 
gender’s physiological variations could be the outcome 
of a prenatal differentiation in the preoptic area of the 
hypothalamus due to an influx of androgens. Thus, 
several molecular circuits has been reported in which 
gonadal hormones are responsible for gender 
differences, there being biomarkers such as sexuality, 
social dominance, disinhibition and aggressiveness 
which are related to testosterone in animals 
(Onyekwere & Ramirez, 1994). 
Indubitably, aggressive behavior involves a complex 
variety of interactions among several hormonal 
systems such as the gonadal – with independent 
activations of androgens and estrogens –, the 
suprarenal, hypothalamus-hypophyseal and even the 
Luteinizing-hormone releasing hormone (LHRH) – 
which stimulates the production of sexual hormones 
both in men and women (Ramirez & Delius; 1979. 
Ramirez & Carrer, 1982). Therefore, from 
investigations based on androgens, specific 
biomarkers could emerge for hormonal systems, this 
being quite helpful in order to predict PD such ASPD. 
For example, a tendency to aggressiveness, visuo-
spatial abilities, and exitability are behavioral 
characteristics in which androgens are generally 
involved; the opposite occurs with estrogens.  
The main thesis which supports the assessment of 
biomarkers associated with testosterone comes from 
the observation of male animals in the majority of 
species. Thus, it is affirmed that high levels of 
testosterone determine the degree of aggression. 
Additionally, over the pubertal development a hormonal 
increase is observed basically in in the hypothalamus-
gonadal and hypothalamus-suprarenal systems. This 
condition explains why some PD traits in many 
adolescents are related to a decrease of the gonadal 
steroids and an increase of estrogens. Hence, it is 
possible to suggest that androgens are involved with 
biomarkers related to aggressive. (Halpern, Udry, 
Campbell, & Suchindran, 1993;). On the other hand, 
two mechanisms could explain why testosterone 
triggers aggressive responses: one is the afferent path 
for the androgens which implicates a relative sexual 
dimorphism of the estrogens in regard with sensibility of 
the tissue to which they are directed. The other one is 
the afferent path for estrogens in which an absolute 
sexual dimorphism is associated with the response 
ability of estrogens to generate aggression.   
Consequently, due to testosterone’s triggering effect in 
aggression and impulsivity, several biomarkers can be 
suggested which are related to PD, although, up to 
now, studies regarding variations in testosterone as an 
activating factor in aggressive or impulsive behavior are 
polemic, and there exists a tendency to rule out that 
aggression and impulsivity levels are modulated 
specifically by this hormone.  
Moreover, the 5-HydroxyindoIeacetic Acid ( ), which is 
a metabolized product of the degradation of the 5-HT, 
has been found in minor concentrations in the 
cerebrospinal fluid (LCR) of patients with PD 
(Constantino, Morris, & Murphy, 1997). The low levels 
of 5-HIAA in LCR (especially in the cortex and the raphe 
nucleus) seem to constitute a molecular signal linked to 
aggression, irritability, hostility and criminal activity 
which are not influenced by the ingestion of either 
medical drugs or psychotropic drugs (Soderstrom, 
Blennow, Manhem, & Forsman, 2001). Thus suggests 
that irritability, hostility and impulsivity activity could 
stand for biomarkers in PD so long as they are related 
to Low levels low levels of 5-HIAA in LCR. 
Also, biomarkers derived from suprarenal hormone’s 
expression could be considered as indicators of 
personality disorder. In this regard, it has been 
proposed that hormones of the hypophysic-suprarenal 
axis – which involve the suprarenal cortex – through 
corticosterone (which stimulates the secretion of 
cortisol) and through the catecholamines adrenaline, 
noradrenaline, are associated with aggression and 
impulsivity so that these traits might be emergent 
biomarkers regarding those circuits. On the other hand, 
the glucocorticoids can inhibit the thyrotropin-releasing 
hormone (TRH) and the stimulating hormone of the 
thyroid (TSH), according to which individuals with 
higher levels of TRH tend to show characteristic 
markers of PD and conditions such as suicidal attempts 
and violent behaviors (Sher et al., 2005).  
In general, cortisol’s main function is to regulate 
biological stress. Specifically, individuals who present 
low levels of cortisol show chronic violence, which is 
closely related to PD (Pajer, Gardner, Rubin, Perel, & 
Neal, 2001). Additionally, it has been registered that 
there exists a positive correlation between the excretion 
of adrenaline and some PD such ASPD. These several 
biomarkers could derive from here. Furthermore, it has 
been shown that there is a close correlation between 
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high levels of noradrenaline in predatory mammals and 
their aggressive and impulsive behaviors (Ramirez, & 
Andreu, 2006). In contrast, Prolactin has evidenced a 
minor response to the agonists of serotonin in 
individuals with PD (Dolan, Deakin, Roberts, & 
Anderson, 2002), which constitutes potential 
biomarkers in psychopathology (Dolan, Deakin, 
Roberts, & Anderson, 2002). 
 
6. NEUROPSYCHOLOGICAL BIOMARKERS AND 
ASSESSMENT TOOLS 
 
In PD there are neuropsychological evidences which 
suggest biomarkers related to an increase in cortical 
arousal which hinders certain psychological abilities 
regarding thinking skills, in particular the interpretation 
of external events, in accordance with a deficit of basic 
mental processes, such as attention, concentration and 
memory. Up to now, the increasing number of 
researches has suggested that deficits in emotional 
processes, patent in PD, could be a biomarker related 
to attention disorders which have a neuropsychological 
origin (Caspi, et al., 2008; Finger et al., 2008; Herpertz 
et al., 2008; Malterer, Glass, & Newman, 2008). 
Furthermore, attention disorders linked to the 
processing of peripheral information and to 
impairments in executive function associated with work 
memory may be putative biomarkers with a close 
relation to the prefrontal cortex (Berman & Coccaro, 
1998; Coccaro, Kavoussi, Berman, & Lish, 1998; 
Sadeh & Verona, 2008). 
The assessment of biomarkers related to executive 
function regards the analysis of complex cognitive 
components involved in the individual’s information 
processing.  Some components may include abstract 
behavior, ethics, planning, self-regulation, ability to 
start, continue and stop planning complex sequences 
of behavior and the regulation of impulses. Some of the 
tools that offer a good sensitivity and allow the 
execution of neutral co-relations, adjusted to 
psychopathy, are the NEUROPSI test (Ostrosky-Solis 
et al., 2007) which evaluates in detail the processes of 
attention and memory (with 27 sub-tests) and allows to 
obtain independent and global rates of both functions. 
Also, to measure the frontal and executive functions, 
Flores and Ostrosky-Solien developed in 2008 a 
diagnostic set of instruments that includes 15 sub-tests 
for monitoring the performance of tasks related with 
orbital, dorsolateral and prefrontal integrity of both brain 
hemispheres. 
All this shows that the assessment of executive 
functions is a fundamental tool in order to derive 
biomarkers related to cognitive and neurological 
variables for PD. Thus, several researchers have used 
alternative tests that help considerably to explain the 
neuronal correlates which are involved in this disorder. 
Some of those test are the Wisconsin Card Sorting Test 
(WCST) (Easton, Sacco, Neavins, Wupperman, & 
George, 2008; Eling, Derckx, & Maes, 2008) which 
evaluates the capacity of abstraction and cognitive 
flexibility (associated with a dorsolateral substrate) 
such that it explains apathy, irritability, and mainly the 
deficits in task-planning.  The deficits in planning have 
been a controversial biomarker since some studies 
involve it in PD. The go-no-go test allows discriminating 
visual-spatial skills, associated with orbifrontal deficits 
which have been observed in subjects with PD and 
which suggest the inability to inhibit impulsive 
responses as a possible biomarker. Moreover, the 
Stroop Test has shown orbifrontal alterations which are 
related neither with deterioration of the dorsolateral 
cortex nor with the cingulated cortex, thus conferring a 
neuropsychological biomarker of brain deterioration in 
these individuals (Blair et al., 2006; Hiatt, Schmitt, & 
Newman, 2004). 
In order to make a synthesis encompassing what has 
so far been mentioned, the following figure is intended 
to depict the relation between PD and different types of 
biomarkers. See figure 1. 
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Figure 1. Depicting the relation between ASPD and biomarkers. 
 
 
 
7. CONCLUSIONS  
 
PD spectrum incorporates certain traits subtypes such 
as dichotomic features. Unfortunately, current 
classifications that categorize PD lack a solid 
neurobiological correlate to delineate or differentiate 
the subtypes. The use of biomarkers to delineate 
personality disroders is fundamental to explain the 
etiology of these patterns of behavior as well as to 
identify their subtypes, which could end up having an 
impact on psychotherapy studies in PD.  
There is still no exclusive biomarker to determine the 
expression of PD. Hence, it is convenient for complex 
clinic and genetic disorders such as behavioral ones to 
take into account the use of several sets of biomarkers. 
Thereby, it is necessary to include the assessment of 
groups of neurobiological, physiological and cognitive 
signals which allow to discern a specific phenotype.  
Also, each brain circuits shows complex constellations 
of behaviors that interact in the modulation of disorders. 
So far, the specific subtypes within PD are related to 
the orbitofrontal, dorsolateral and medial cingulate 
areas. However, neurobiological studies have yet not 
been able to locate a brain zone to explain the subtypes 
of PD. This condition is the result of an imbalance 
between stimulation and inhibition of different brain 
zones regarding a specific stimulus. In addition, current 
difficulties in approaching PD and their subtypes  that 
constitute dimensions together with the differential 
expression of other comorbid syndromes and about 
which important clinical, neuropsychological, 
neurophysiological, biochemical and genetic 
differences are established (for example, age related 
with the severity of symptoms, the conduct disorder 
with or without child abuse and so on) (Evenden, 1999; 
Morgan & Lilienfeld, 2000; Sevecke, Lehmkuhl, & 
Krischer, 2008) suggest  the necessity to advance in 
the taxonomy of theses syndromes through the use of 
several biomarkers that help to discriminate the 
subtype and establish a differential biological correlate. 
An exhaustive approximation to the spectrum of PD 
must include biomarkers that are co-related closely with 
impulsive subtypes, aggressive subtypes, and 
neurocognitive features associated with the patterns of 
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behavior. These allow the distinction of the behavioral 
prototypes and the delineation of the genes that act in 
the expression of these patterns and in the interaction 
gene-environment, the epistatic phenomena and 
pleiotropism, as molecular phenomena that execute a 
potentially modulating effect of the clinical feature.  
Finally, this review aims to the development of 
phenomics, a concept recently introduced by Niculescu 
and Kelsoe in 2002 (Sabb et al., 2008), based on the 
characterization of phenotypes as a whole 
phenomenon (the phenotype and its interaction 
between genome and environment) that implies the 
recognition of critical features that delineate the clinical 
phenotype through multiple levels of intermediate traits.  
In fact, the psychiatric researchers are focusing around 
neurobiological and genetic traits linked with phenotype 
selection and specific clinical biomarkers and 
endophenotypes. Traits such as response inhibition, 
ERPs, emotional processing in PD are not unitary 
concepts; rather they are a potential construct in 
assessing specific tests. The reliability and validity of 
this fashion can be evaluated with different methods 
which enable inferences about the truth of the latent 
model (candidate biomarkers or putative 
endophenotypes). Therefore, understanding 
phenomics could also help to choose key phenotypes 
for psychiatric research. 
 
8. FUTURE WORK 
 
The study of endophenotypes and biomarkers in PD will 
provide strong empirical evidence which will help with 
the development of new elements to improve 
psychotherapies focused in specific alterations of the 
patients with these disorders. Traits associated with 
psychobiological or cognitive impairments will be 
understood and recognized by the health care system, 
psychiatrics and families.  
Future research will include newer and more effective 
electrophysiological techniques available for 
neurocognitive, genetic, and clinical research. This 
tools will help to discover new genes associated with 
these disorders, new treatments as well as for a wide 
range of clinical applications.(Kamarajan & Porjesz, 
2015) It is important to mention that the development of 
neuroimaging techniques have been enhanced in 
recent years, but their implement on the research of PD 
represents a recent issue.  
Finally, a variety of new sophisticated statistical 
techniques could allow systematic research to highlight 
longitudinal aspects such as the cognitive development 
and the course of these disorders under research 
(Kamarajan & Porjesz, 2015). 
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